Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Mudianto, Tenny T; Campbell, Katie M KM; Webb, Jason J; Zolkind, Paul P; Skidmore, Zachary L ZL; Riley, Rachel R; Barnell, Erica K EK; Ozgenc, Ibrahim I; Giri, Tusar T; Dunn, Gavin P GP; Adkins, Douglas R DR; Griffith, Malachi M; Egloff, Ann Marie AM; Griffith, Obi L OL; Uppaluri, Ravindra R
Integrated molecular drivers coordinate biological and clinical states in melanoma.
Nature Genetics
Conway, Jake R JR; Dietlein, Felix F; Taylor-Weiner, Amaro A; AlDubayan, Saud S; Vokes, Natalie N; Keenan, Tanya T; Reardon, Brendan B; He, Meng Xiao MX; Margolis, Claire A CA; Weirather, Jason L JL; Haq, Rizwan R; Schilling, Bastian B; Stephen Hodi, F F; Schadendorf, Dirk D; Liu, David D; Van Allen, Eliezer M EM
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
Cell Reports
Way, Gregory P GP; Sanchez-Vega, Francisco F; La, Konnor K; Armenia, Joshua J; Chatila, Walid K WK; Luna, Augustin A; Sander, Chris C; Cherniack, Andrew D AD; Mina, Marco M; Ciriello, Giovanni G; Schultz, Nikolaus N; , ; Sanchez, Yolanda Y; Greene, Casey S CS
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics.
Molecular Oncology
Cirenajwis, Helena H; Lauss, Martin M; Ekedahl, Henrik H; Törngren, Therese T; Kvist, Anders A; Saal, Lao H LH; Olsson, Håkan H; Staaf, Johan J; Carneiro, Ana A; Ingvar, Christian C; Harbst, Katja K; Hayward, Nicholas K NK; Jönsson, Göran G
p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.
Genes & Development
Brichkina, Anna A; Bertero, Thomas T; Loh, Hui Mun HM; Nguyen, Nguyet Thi Minh NT; Emelyanov, Alexander A; Rigade, Sidwell S; Ilie, Marius M; Hofman, Paul P; Gaggioli, Cedric C; Bulavin, Dmitry V DV
A Landscape of Pharmacogenomic Interactions in Cancer.
Cell
Iorio, Francesco F; Knijnenburg, Theo A TA; Vis, Daniel J DJ; Bignell, Graham R GR; Menden, Michael P MP; Schubert, Michael M; Aben, Nanne N; Gonçalves, Emanuel E; Barthorpe, Syd S; Lightfoot, Howard H; Cokelaer, Thomas T; Greninger, Patricia P; van Dyk, Ewald E; Chang, Han H; de Silva, Heshani H; Heyn, Holger H; Deng, Xianming X; Egan, Regina K RK; Liu, Qingsong Q; Mironenko, Tatiana T; Mitropoulos, Xeni X; Richardson, Laura L; Wang, Jinhua J; Zhang, Tinghu T; Moran, Sebastian S; Sayols, Sergi S; Soleimani, Maryam M; Tamborero, David D; Lopez-Bigas, Nuria N; Ross-Macdonald, Petra P; Esteller, Manel M; Gray, Nathanael S NS; Haber, Daniel A DA; Stratton, Michael R MR; Benes, Cyril H CH; Wessels, Lodewyk F A LFA; Saez-Rodriguez, Julio J; McDermott, Ultan U; Garnett, Mathew J MJ
Ryan, S L SL; Matheson, E E; Grossmann, V V; Sinclair, P P; Bashton, M M; Schwab, C C; Towers, W W; Partington, M M; Elliott, A A; Minto, L L; Richardson, S S; Rahman, T T; Keavney, B B; Skinner, R R; Bown, N N; Haferlach, T T; Vandenberghe, P P; Haferlach, C C; Santibanez-Koref, M M; Moorman, A V AV; Kohlmann, A A; Irving, J A E JA; Harrison, C J CJ
LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.
Bmc Bioinformatics
Melloni, Giorgio E M GE; de Pretis, Stefano S; Riva, Laura L; Pelizzola, Mattia M; Céol, Arnaud A; Costanza, Jole J; Müller, Heiko H; Zammataro, Luca L
Recurrent inactivating RASA2 mutations in melanoma.
Nature Genetics
Arafeh, Rand R; Qutob, Nouar N; Emmanuel, Rafi R; Keren-Paz, Alona A; Madore, Jason J; Elkahloun, Abdel A; Wilmott, James S JS; Gartner, Jared J JJ; Di Pizio, Antonella A; Winograd-Katz, Sabina S; Sindiri, Sivasish S; Rotkopf, Ron R; Dutton-Regester, Ken K; Johansson, Peter P; Pritchard, Antonia L AL; Waddell, Nicola N; Hill, Victoria K VK; Lin, Jimmy C JC; Hevroni, Yael Y; Rosenberg, Steven A SA; Khan, Javed J; Ben-Dor, Shifra S; Niv, Masha Y MY; Ulitsky, Igor I; Mann, Graham J GJ; Scolyer, Richard A RA; Hayward, Nicholas K NK; Samuels, Yardena Y
Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer.
Bmc Pharmacology & Toxicology
Nichols, Anthony C AC; Black, Morgan M; Yoo, John J; Pinto, Nicole N; Fernandes, Andrew A; Haibe-Kains, Benjamin B; Boutros, Paul C PC; Barrett, John W JW
A highly recurrent RPS27 5'UTR mutation in melanoma.
Oncotarget
Dutton-Regester, Ken K; Gartner, Jared J JJ; Emmanuel, Rafi R; Qutob, Nouar N; Davies, Michael A MA; Gershenwald, Jeffrey E JE; Robinson, William W; Robinson, Steven S; Rosenberg, Steven A SA; Scolyer, Richard A RA; Mann, Graham J GJ; Thompson, John F JF; Hayward, Nicholas K NK; Samuels, Yardena Y
Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib.
Clinical And Translational Science
Hickinson, D Mark DM; Marshall, Gayle B GB; Beran, Garry J GJ; Varella-Garcia, Marileila M; Mills, Elizabeth A EA; South, Marie C MC; Cassidy, Andrew M AM; Acheson, Kerry L KL; McWalter, Gael G; McCormack, Rose M RM; Bunn, Paul A PA; French, Tim T; Graham, Alex A; Holloway, Brian R BR; Hirsch, Fred R FR; Speake, Georgina G
B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.
Plos One
Ugurel, Selma S; Thirumaran, Ranjit K RK; Bloethner, Sandra S; Gast, Andreas A; Sucker, Antje A; Mueller-Berghaus, Jan J; Rittgen, Werner W; Hemminki, Kari K; Becker, Jürgen C JC; Kumar, Rajiv R; Schadendorf, Dirk D